Published January 2020
| Version v1
Miscellaneous
Restricted
Contamination during an injection: how to manage the risks associated with extravasation?
Description
When a drug is injected, it may spread outside the vein. This is known as extravasation. What are the recommendations for preventing this incident, and how should the patient be managed in the case of a radiopharmaceutical? Find the answers in this dossier
Files
Restricted
The record is publicly accessible, but files are restricted to users with access.
Additional details
Additional titles
- Original title (French)
- Contamination lors d'une injection: comment gerer les risques lies a l'extravasation?
Publishing Information
- Imprint Pagination
- 7 p.
- Report number
- INIS-FR--24-1989
INIS
- Country of Publication
- France
- Country of Input or Organization
- France
- INIS RN
- 56003336
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S61: RADIATION PROTECTION AND DOSIMETRY;
- Descriptors DEI
- ABSORBED RADIATION DOSES; DOSIMETRY; INTRAVENOUS INJECTION; LUTETIUM 177; PATIENTS; RADIOPHARMACEUTICALS; RECOMMENDATIONS; SCINTISCANNING
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; COUNTING TECHNIQUES; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DOSES; DRUGS; INJECTION; INTAKE; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LUTETIUM ISOTOPES; MATERIALS; NUCLEI; ODD-EVEN NUCLEI; RADIATION DOSES; RADIOACTIVE MATERIALS; RADIOISOTOPE SCANNING; RADIOISOTOPES; RARE EARTH NUCLEI
Optional Information
- Notes
- 2 refs.; Available from the INIS Liaison Officer for France, see the INIS website for current contact and E-mail addresses